focus -WSS

focus

author：hotspot 2025-08-23 23:19:59 - browse：1818

U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s main trade group has told Congress.

Congress is considering legislation, called the BIOSECURE Act, that would make it difficult for Chinese contract development and manufacturing organizations to do business with biotechnology companies that work with the U.S. federal government. Biotechs hire Chinese CDMOs, as they’re often called, for services that include product manufacturing, development, formulation, packaging, and distribution.

The BIOSECURE Act would stop the federal government from contracting with, or providing grants to, companies that do business with so-called Chinese “companies of concern.” The impact of the legislation would depend in large part on who is in the White House. The White House’s Office of Management and Budget would determine which companies are blacklisted, but a handful of specific companies would automatically go on that list, including the biotech giant WuXi AppTec.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： After a decade, new Gardasil ad campaign gets it (mostly) right

WSS

Eat, drink, but be wary — 4 foods that interact with medications

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

There’s a way to spot data fakery. All journals should be using it

Sanders wants to replace patents with prizes for drug inventions

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Drug repurposing or repositioning? The language matters

There’s a way to spot data fakery. All journals should be using it

Anesthesiologist group: stop taking Ozempic before surgery

Climate activists disrupt London Pride march to protest corporate sponsorship

How one medical school became remarkably diverse

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Sports medicine is finally prioritizing gender equality

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Pediatricians' group reaffirms support for gender

focus

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Prosecutors seek bail revocation for FTX founder Sam Bankman

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Caribou posts encouraging results on off

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Wikipedia

leisure time

explore

entertainment